Nic-Hit

Natural health product licensed in Canada

Licence holder

Euro-Pharm International Canada Inc.

NPN or DIN-HM

80059869

Status

Active licence

Licence date

13 April 2015

Revision date

Not provided

Form

Pastille

Route of administration

Buccale

Application type

Non traditionnelle

Composition

Medicinal composition not provided.

Non-medicinal ingredients

D-Mannitol, gomme acacia, Glycosides de stéviol, Dioxyde de titane, Stéarate de magnésium, Poly(alcool vinylique), Caprylate de glycéryle/Caprate, Talc, xylitol, Amidon de maïs, Saveur, Lauryl sulfate de sodium, Coconut Oil, Carboxyméthylcellulose, Microcrystalline cellulose

Recommended doses in Canada

Uses authorised in Canada

Text supplied in English because no French text is available.

Stop smoking aid. Nic-Hit lozenges can help you stop smoking by reducing withdrawal symptoms, including nicotine cravings associated with quitting smoking. To be used as part of a comprehensive smoking cessation program.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80059869

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.